Tradestie Institutional Equity Comparison Engine

BGM vs CRON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRON Overall Edge

CRON Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cronos Group Inc. Common Share (CRON) driven by superior Valuation, Growth & Margin, Options & Structure while BGM counters with relative strength in Momentum & Technical. Fundamentally, BGM trades at N/M Forward P/E with -23.4% operating margin (+69.8% YoY revenue) versus CRON at 12.0x Forward P/E and 6.1% operating margin (+74.6% YoY). In options structure, BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CRON sits in CONSOLIDATION (20th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRON
BGM N/M vs CRON 12.0x Fwd P/E
Growth & Margin Winner CRON
Op Margin -23.4% vs 6.1% ยท YoY +69.8% vs +74.6%
Momentum & Technical Winner BGM
1Y -17.5% vs +28.8% ยท 52W Pos 74% vs 47%
Options & Structure Winner CRON
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (20th %ile IV)
BGM NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap $108.6M
1M Return -21.57%
1Y Return -17.53%
Forward P/E N/M
Unified AI Score
59.6 / 100 HOLD
Tech 65.0 Fund 55.0 Flow 50.0 Mom 50.0
CRON NASDAQ
Cronos Group Inc. Common Share
Medicinal Chemicals & Botanical Products
$3.04
-1.3% 1D
Market Cap $1.1B
1M Return -11.76%
1Y Return +28.81%
Forward P/E 12.0x
Unified AI Score
53.4 / 100 HOLD
Tech 27.0 Fund 47.0 Flow 58.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BGM -17.53% CRON +28.81% Spread: +36.28 pp (CRON Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BGM TTM Op. Margin: -23.4% CRON TTM Op. Margin: 6.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGM vs CRON. Trailing 12-month operating profitability (BGM -23.4% vs CRON 6.1%) and valuation multiples (BGM N/M vs CRON 12.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BGM (2) vs CRON (8)
Institutional Metric BGM CRON Criterion Row Winner
Market Capitalization Scale $108.6M $1.1B Larger Scale CRON
Trailing P/E Ratio Valuation N/M 19.2x Lower Multiple CRON
Forward P/E Ratio Valuation N/M 12.0x Lower Multiple CRON
Revenue Growth (YoY) Growth +69.8% +74.6% Higher Growth CRON
Operating Margin (TTM) Profitability -23.4% 6.1% Higher Margin CRON
Net Profit Margin Profitability -44.2% 28.0% Higher Margin CRON
Return on Equity (ROE) Capital Efficiency -7.4% 6.1% Higher ROE CRON
52-Week Range Position Momentum 74% ($0โ€“$11) 47% ($2โ€“$4) Stronger Trend BGM
Beta / 30D Volatility Risk Regime 3.69ฮฒ ยท 80% Vol 0.36ฮฒ ยท 38% Vol Lower Realized Risk CRON
Unified Institutional Score Composite Signal 59.6 / 100 (HOLD) 53.4 / 100 (HOLD) Higher Composite BGM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BGM vs CRON Buy Guide
BGM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BGM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRON CONSOLIDATION
61d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live CRON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BGM nor CRON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.